Bragar Eagel & Squire, P.C. Launches Investigation into Avita, Coty, and Sensus, Urging Investors to Reach Out to the Firm
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 04 2025
0mins
Should l Buy COTY?
Source: Globenewswire
AVITA Medical Investigation: Bragar Eagel & Squire, P.C. is investigating AVITA Medical for potential violations of federal securities laws after the company reported a significant backlog of unpaid claims for its Recell procedures, leading to a 21% drop in stock price.
Coty Inc. Financial Results: Coty Inc. faced scrutiny following an unexpected loss and disappointing guidance in its fiscal year 2025 results, attributed to market challenges, resulting in a 21.6% decline in stock price.
Sensus Healthcare Earnings Miss: Sensus Healthcare is under investigation after reporting a GAAP earnings-per-share miss and a 20.7% year-over-year revenue decline, causing its stock price to plummet by 35.32%.
Law Firm Overview: Bragar Eagel & Squire, P.C. is a law firm specializing in representing investors in complex litigation, with offices in New York, California, and South Carolina.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COTY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COTY
Wall Street analysts forecast COTY stock price to rise
12 Analyst Rating
1 Buy
9 Hold
2 Sell
Hold
Current: 2.300
Low
2.50
Averages
4.30
High
10.00
Current: 2.300
Low
2.50
Averages
4.30
High
10.00
About COTY
Coty Inc. is a beauty company with a portfolio of brands across fragrance, color cosmetics, and skin and body care. The Company has a diverse portfolio of brands, which includes both owned and licensed. Its brand portfolio is classified into two segments: Consumer beauty and Prestige. The consumer beauty brands include Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Mexx, LeGer by Lena Gercke, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, and Vera Wang. Its prestige brands include Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, and Tiffany & Co. Its mass beauty brands are primarily sold through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, traditional food and drug retailers, and dedicated e-commerce retailers. It markets, sells and distributes its products in over 120 countries and territories.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Coty Under Investigation Amid 15.56% Stock Drop Following Earnings Miss
- Earnings Miss: Coty reported non-GAAP earnings per share of $0.14 for Q2 FY2026, missing consensus estimates by $0.04, indicating a decline in profitability that could undermine investor confidence.
- Guidance Withdrawal: The company withdrew its full-year 2026 guidance and introduced a turnaround strategy focused on core brands, which may increase operational uncertainty in the short term.
- Stock Price Reaction: Following the earnings report, Coty's stock price fell by $0.49, or 15.56%, closing at $2.66 per share on February 6, 2026, reflecting market concerns about the company's future outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Coty and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and financial losses, impacting the company's reputation and shareholder interests.
See More
Olaplex Faces Investor Confidence Crisis
- Stock Price Plunge: Since its IPO in 2021, Olaplex's stock has plummeted nearly 95%, currently trading below $1.50 with a market cap of approximately $1 billion, indicating a significant decline in the company's market competitiveness.
- Sales Performance Decline: In fiscal year 2023, Olaplex reported a 47.8% year-over-year decrease in net sales in the U.S. and a 74.8% drop in net income, reflecting severe challenges from weakened consumer demand and loss of market share to emerging brands.
- Brand Revitalization Challenges: Although new CEO Amanda Baldwin sees
See More
Three Undervalued Consumer Companies to Watch
- Adecoagro's Bioeconomy Shift: Adecoagro is converting vinasse into biomethane, aiming to quintuple production to 30,000 cubic meters daily by 2027, enough to replace 10 million liters of diesel annually, significantly enhancing its renewable energy competitiveness.
- Dole's Brand Modernization: Dole sold its low-margin Fresh Vegetables division for $140 million to focus on fruit, while integrating sales platforms to strengthen market share in fast-growing categories like avocados and blueberries, potentially driving its $9 billion global revenue growth.
- Coty's Fragrance Restructuring: Under interim CEO, Coty is pivoting to the prestige fragrance market, with ultra-premium collections seeing a 17% revenue increase in Q1, and plans to launch new products targeting Gen Z consumers, which could enhance market share and margins.
- Market Sentiment and Investment Potential: Despite skepticism from the market, the strategic shifts and growth opportunities in these companies suggest that a $500 investment could yield significant returns in the coming years, particularly in bioeconomy and premium consumer goods sectors.
See More
Coty Under Investigation Amid 15.56% Stock Drop Following Earnings Miss
- Earnings Miss: Coty reported non-GAAP earnings per share of $0.14 for Q2 FY2026, missing consensus estimates by $0.04, indicating a decline in profitability that may undermine investor confidence.
- Guidance Withdrawal: The company withdrew its full-year 2026 guidance and introduced a turnaround strategy focused on core brands, a move that could significantly impact its future market performance.
- Stock Price Reaction: Following the earnings report, Coty's stock price fell by $0.49, or 15.56%, closing at $2.66 per share, reflecting market concerns about the company's outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Coty and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and financial repercussions.
See More
Target Revamps Merchandise Strategy to Attract Shoppers
- Merchandise Strategy Overhaul: Target plans to revamp its merchandise strategy over the next year, expecting net sales to rise about 2% compared to last year, addressing the challenge of four consecutive quarters of declining customer traffic.
- Fresh Food Expansion: The company will expand the square footage dedicated to fresh foods, planning to double the space in over half of its remodeled stores, aiming to attract more customers for one-stop shopping.
- Beauty Product Upgrade: Target will launch a 'Beauty Studio' in over 600 stores, replacing its partnership with Ulta Beauty, focusing on prestige beauty brands to attract younger consumers and boost sales.
- Home Goods Reconstruction: With home goods sales declining nearly 7% year-over-year, Target plans to rebuild the display area for these products over the next few years, expecting to redesign 75% of its home decor items to regain market competitiveness.
See More
Coty Under Investigation, Stock Plummets 15.56%
- Poor Financial Performance: Coty reported non-GAAP earnings per share of $0.14 for Q2 FY2026, missing consensus estimates by $0.04, indicating a decline in profitability that may undermine investor confidence.
- Withdrawal of Full-Year Guidance: The company withdrew its full-year 2026 guidance and introduced a turnaround strategy focused on core brands, which could impact future market performance and investor expectations.
- Significant Stock Decline: Following the earnings report, Coty's stock price fell by $0.49, or 15.56%, closing at $2.66 per share on February 6, 2026, reflecting market concerns about the company's outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Coty and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and financial losses, affecting the company's reputation and shareholder interests.
See More
Coty Under Investigation Amid 15.56% Stock Drop Following Earnings Miss
- Earnings Miss: Coty reported non-GAAP earnings per share of $0.14 for Q2 FY2026, missing consensus estimates by $0.04, indicating a decline in profitability that could undermine investor confidence.
- Guidance Withdrawal: The company withdrew its full-year 2026 guidance and introduced a turnaround strategy focused on core brands, which may increase operational uncertainty in the short term.
- Stock Price Reaction: Following the earnings report, Coty's stock price fell by $0.49, or 15.56%, closing at $2.66 per share on February 6, 2026, reflecting market concerns about the company's future outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Coty and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and financial losses, impacting the company's reputation and shareholder interests.
See More
Olaplex Faces Investor Confidence Crisis
- Stock Price Plunge: Since its IPO in 2021, Olaplex's stock has plummeted nearly 95%, currently trading below $1.50 with a market cap of approximately $1 billion, indicating a significant decline in the company's market competitiveness.
- Sales Performance Decline: In fiscal year 2023, Olaplex reported a 47.8% year-over-year decrease in net sales in the U.S. and a 74.8% drop in net income, reflecting severe challenges from weakened consumer demand and loss of market share to emerging brands.
- Brand Revitalization Challenges: Although new CEO Amanda Baldwin sees
See More
Three Undervalued Consumer Companies to Watch
- Adecoagro's Bioeconomy Shift: Adecoagro is converting vinasse into biomethane, aiming to quintuple production to 30,000 cubic meters daily by 2027, enough to replace 10 million liters of diesel annually, significantly enhancing its renewable energy competitiveness.
- Dole's Brand Modernization: Dole sold its low-margin Fresh Vegetables division for $140 million to focus on fruit, while integrating sales platforms to strengthen market share in fast-growing categories like avocados and blueberries, potentially driving its $9 billion global revenue growth.
- Coty's Fragrance Restructuring: Under interim CEO, Coty is pivoting to the prestige fragrance market, with ultra-premium collections seeing a 17% revenue increase in Q1, and plans to launch new products targeting Gen Z consumers, which could enhance market share and margins.
- Market Sentiment and Investment Potential: Despite skepticism from the market, the strategic shifts and growth opportunities in these companies suggest that a $500 investment could yield significant returns in the coming years, particularly in bioeconomy and premium consumer goods sectors.
See More
Coty Under Investigation Amid 15.56% Stock Drop Following Earnings Miss
- Earnings Miss: Coty reported non-GAAP earnings per share of $0.14 for Q2 FY2026, missing consensus estimates by $0.04, indicating a decline in profitability that may undermine investor confidence.
- Guidance Withdrawal: The company withdrew its full-year 2026 guidance and introduced a turnaround strategy focused on core brands, a move that could significantly impact its future market performance.
- Stock Price Reaction: Following the earnings report, Coty's stock price fell by $0.49, or 15.56%, closing at $2.66 per share, reflecting market concerns about the company's outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Coty and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and financial repercussions.
See More
Target Revamps Merchandise Strategy to Attract Shoppers
- Merchandise Strategy Overhaul: Target plans to revamp its merchandise strategy over the next year, expecting net sales to rise about 2% compared to last year, addressing the challenge of four consecutive quarters of declining customer traffic.
- Fresh Food Expansion: The company will expand the square footage dedicated to fresh foods, planning to double the space in over half of its remodeled stores, aiming to attract more customers for one-stop shopping.
- Beauty Product Upgrade: Target will launch a 'Beauty Studio' in over 600 stores, replacing its partnership with Ulta Beauty, focusing on prestige beauty brands to attract younger consumers and boost sales.
- Home Goods Reconstruction: With home goods sales declining nearly 7% year-over-year, Target plans to rebuild the display area for these products over the next few years, expecting to redesign 75% of its home decor items to regain market competitiveness.
See More
Coty Under Investigation, Stock Plummets 15.56%
- Poor Financial Performance: Coty reported non-GAAP earnings per share of $0.14 for Q2 FY2026, missing consensus estimates by $0.04, indicating a decline in profitability that may undermine investor confidence.
- Withdrawal of Full-Year Guidance: The company withdrew its full-year 2026 guidance and introduced a turnaround strategy focused on core brands, which could impact future market performance and investor expectations.
- Significant Stock Decline: Following the earnings report, Coty's stock price fell by $0.49, or 15.56%, closing at $2.66 per share on February 6, 2026, reflecting market concerns about the company's outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Coty and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and financial losses, affecting the company's reputation and shareholder interests.
See More
